Pasithea Therapeutics Corp. (KTTA)
KTTA Stock Price Chart
Explore Pasithea Therapeutics Corp. interactive price chart. Choose custom timeframes to analyze KTTA price movements and trends.
KTTA Company Profile
Discover essential business fundamentals and corporate details for Pasithea Therapeutics Corp. (KTTA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Sept 2021
Employees
4.00
Website
https://www.pasithea.comCEO
Tiago Reis Marques
Description
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
KTTA Financial Timeline
Browse a chronological timeline of Pasithea Therapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.16, while revenue estimate is $300.00k.
Earnings released on 3 Jun 2026
Earnings released on 15 May 2026
EPS came in at -$0.12 surpassing the estimated -$0.45 by +73.33%.
Earnings released on 30 Mar 2026
EPS came in at -$0.89 falling short of the estimated -$0.18 by -394.44%.
Earnings released on 25 Feb 2026
EPS came in at -$0.18 matching the estimated -$0.18.
Earnings released on 13 Nov 2025
EPS came in at -$0.41 .
Earnings released on 14 Aug 2025
EPS came in at -$0.66 .
Earnings released on 15 May 2025
EPS came in at -$1.61 .
Earnings released on 24 Mar 2025
EPS came in at -$2.41 .
Earnings released on 13 Nov 2024
EPS came in at -$2.87 .
Earnings released on 13 Aug 2024
EPS came in at -$3.71 .
Earnings released on 14 May 2024
EPS came in at -$3.70 .
Earnings released on 28 Mar 2024
EPS came in at -$4.85 falling short of the estimated -$3.80 by -27.54%, while revenue for the quarter reached $976.31k .
Stock split effective on 2 Jan 2024
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Dec 2023
EPS came in at -$2.87 surpassing the estimated -$3.60 by +20.23%.
Earnings released on 11 Aug 2023
EPS came in at -$2.88 surpassing the estimated -$3.40 by +15.28%.
Earnings released on 12 May 2023
EPS came in at -$211.05 falling short of the estimated -$3.40 by -6.11k%.
Earnings released on 30 Mar 2023
EPS came in at -$3.00 surpassing the estimated -$3.40 by +11.86%, while revenue for the quarter reached $240.71k , missing expectations by -19.76%.
Earnings released on 14 Nov 2022
EPS came in at -$3.45 falling short of the estimated -$3.40 by -1.61%, while revenue for the quarter reached $218.61k , beating expectations by +9.30%.
Earnings released on 15 Aug 2022
EPS came in at -$0.08 surpassing the estimated -$2.20 by +96.48%, while revenue for the quarter reached $13.58k .
Earnings released on 16 May 2022
EPS came in at -$0.07 falling short of the estimated -$0.02 by -250.00%, while revenue for the quarter reached $13.66k , missing expectations by -95.45%.
Earnings released on 30 Mar 2022
EPS came in at $0.12 surpassing the estimated -$0.05 by +340.00%, while revenue for the quarter reached $15.06k , missing expectations by -84.94%.
Earnings released on 18 Nov 2021
EPS came in at -$0.17 .
Earnings released on 16 Sept 2021
EPS came in at -$0.04 .
KTTA Stock Performance
Access detailed KTTA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
